Apceth GmbH & Co. KG
🇩🇪Germany
Treatment of Advanced Gastrointestinal Cancer in a Phase I/II Trial With Modified Autologous MSC_apceth_101
- First Posted Date
- 2013-12-11
- Last Posted Date
- 2017-03-27
- Lead Sponsor
- Apceth GmbH & Co. KG
- Target Recruit Count
- 13
- Registration Number
- NCT02008539
- Locations
- 🇩🇪
University Hospital Munich, Munich, Germany
Tolerability and Efficacy of Intravenous Infusion of Autologous MSC_Apceth for the Treatment of Critical Limb Ischemia
Phase 1
Completed
- Conditions
- Critical Limb IschemiaPeripheral Artery Disease
- Interventions
- Procedure: PTABiological: PTA + Infusion of MSC_Apceth
- First Posted Date
- 2011-05-11
- Last Posted Date
- 2015-12-15
- Lead Sponsor
- Apceth GmbH & Co. KG
- Target Recruit Count
- 25
- Registration Number
- NCT01351610
- Locations
- 🇩🇪
Isar Medizin Zentrum, Munich, Bavaria, Germany
© Copyright 2025. All Rights Reserved by MedPath